TCTAP C-131 PDA Closure in a Special Circumstance

Percutaneous transcatheter PDA device closure in infancy.

OBJECTIVE To evaluate the results and complications associated with transcatheter closure of patent ductus arteriosus (PDA) in infants. STUDY DESIGN Quasi-experimental study. PLACE AND DURATION OF STUDY Paediatric Cardiology Department of Armed Forces Institute of Cardiology / National Institute of Heart Diseases (AFIC/NIHD), Rawalpindi, from December 2010 to June 2012. METHODOLOGY Infant...

Percutaneous PDA Closure in Extremely Low Birth Weight Babies.

AIM Patent Ductus Arteriosus is an important cause of morbidity and mortality in preterms. As birth weight decrease, risks increase. Main aim of our study is to emphasize the effectiveness and safety of percutaneous PDA closure even in extremely low birth infants. MATERIALS AND METHODS In our center between the dates June 2014-June 2016, PDA of 10 patients less than 1,000 gr were closed percu...

Use of rectal ibuprofen for PDA closure in preterm neonates

Objective To evaluate efficacy and safety of rectal form of ibuprofen and comparing to indomethacin for treatment of patent ductus arteriosus (PDA) in premature neonates. Methods Single-center, cohort, prospective study without prerandomization was performed in 38 preterm infants at gestational age 25-31 weeks were treated in NICU of Dnepropetrovsk Regional Children's Hospital (Ukraine) during ...

Pda Pda Pda

Transcathater percutaneous device closure of a large PDA closed in a 3 kg infant.

Patent ductus arteriosus (PDA) is common congenital heart disease which may require treatment as transcatheter percutaneous device closure (PDA device closure) or surgical ligation in symptomatic full-term patients. Surgical ligation is an invasive procedure and has more complications especially in the neonates. Problems in PDA device closure are difficult vascular access, manipulation of cathe...